NICKEL TARTRATE

[Ni++].O[C@H]([C@@H](O)C([O-])=O)C([O-])=O

InChIKey=XRLUJVFOGKUSMQ-ZVGUSBNCSA-L

InChI=1S/C4H6O6.Ni/c5-1(3(7)8)2(6)4(9)10;/h1-2,5-6H,(H,7,8)(H,9,10);/q;+2/p-2/t1-,2-;/m1./s1

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Nickel tatrate a salt of tatric acid. It is used as a catalyst for enantioselective hydrogenation.

Conditions

Condition	Modality	Targets	Highest Phase	Product
Unknown 2578

PubMed

Title	Date	PubMed
From local adsorption stresses to chiral surfaces: (R,R)-tartaric acid on Ni(110).	2002 Jan 23	11792223

Patents

In Vivo Use Guide

Unknown

Route of Administration: Unknown

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Fri Dec 15 17:52:46 GMT 2023` Edited by `admin` on `Fri Dec 15 17:52:46 GMT 2023`
Record UNII	8XOZ193139
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

NICKEL TARTRATE

Systematic Name

English

BUTANEDIOIC ACID,2,3-DIHYDROXY- ( 2R,3R)-, NICKEL SALT (1:1)

Common Name

English

Nickel tartrate [WHO-DD]

Common Name

English

Code System Code Type Description

FDA UNII

8XOZ193139